packageLevosimendan

levosimendan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Levosimendan is a calcium sensitiser used to treat acutely decompensated congestive heart failure. It is an approved cardiac stimulant, though its use appears limited and it has also been investigated and withdrawn in some settings.

Summary written by glm-5.3-flash from Wikidata Q162541 and the WHO ATC classification; not checked by a person.

name:levosimendan
ATC codes:C01CX08
DrugBank:DB00922
PubChem CID:3033825
ChEBI:50567
Wikidata:Q162541
formula:C14H12N6O
molar mass:280.291 g/mol (PubChem CID 3033825)
logP:2.3 (Drugs.Common 25.09, not verified)

Metabolites

OR1855OR-1855203.245 g/mol (pubchem)
OR1896OR-1896245.282 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
OR1855metabolite: OR-1855
OR1896metabolite: OR-1896